• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Glaxo starts development of new drugs and new test centers in India, South Asia

      Posted AtIndia Daily

      Glaxo plans to open six centres on the Indian subcontinent to test promising products such as Lapatinib for Breast Cancer and Cervarixits, its potential blockbuster vaccine against cervical cancer.

      GlaxoSmithKline has signed a groundbreaking deal with Oxford University to develop experimental cancer drugs in India, writes Ian Lyall.

      The move underlines India's appeal as a low-cost base for research, though GSK stressed it would not be cutting highly- skilled lab jobs in the UK.

      NHS bureaucracy means not all patient trials can be carried out in British hospitals. India, with its huge population and thousands of doctors and researchers, has proved the ideal test-bed for international drugs firms.

      "The UK remains our key research and development base," said GSK. "This collaboration will spread UK expertise and best practice to India."

      According to health information firm IMS Health, cancer drug sales will rise by up to18pc next year.

      November 18, 2005


      Share this Article!

    Back to top^